Diagnosis and treatment of choroidal melanoma
Carol L Cox Professor of nursing, Department of Applied Biological Sciences, School of Community and Health Sciences, City University London
Helen Gibbons Researcher practitioner, Department of Applied Biological Sciences, City University London and Moorfields Eye Hospital NHS Foundation Trust, London
Patricia Evans Lecturer practitioner, Moorfields Eye Hospital NHS Foundation Trust and School of Community and Health Sciences, City University London
Jasmine Thombs Ophthalmic nurse counsellor, Moorfields Eye Hospital NHS Foundation Trust, London
Carol Cox and colleagues describe the symptoms and management of this common primary malignancy of the eye and look at the role of the ophthalmic nurse specialist in providing information and supporting patients at each stage of treatment
This article explores choroidal melanoma, the most common primary malignancy of the eye. Two case studies are presented and there is discussion of the nursing implications after enucleation, plaque brachytherapy and transpupillary thermotherapy. Throughout the patient journey the ophthalmic nurse specialist engages in empathetic management, including physical care, moral support and the provision of guidance on potential facial disfigurement and lack of available treatment for metastatic disease.
Cancer Nursing Practice.
9, 6, 12-17.
doi: 10.7748/cnp2010.07.9.6.12.c7896
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
